# Multi-Omics and Molecular Docking Reveal That Oats and Oat Bran Alleviate Chronic Colitis Via IL-17 Pathway Modulation

**Authors:** Wen Duan, Tong Li, Yuyu Zhang, Baoguo Sun, Rui Hai Liu

PMC · DOI: 10.3390/nu18030407 · Nutrients · 2026-01-26

## TL;DR

Oats and oat bran may help reduce chronic colitis by affecting the IL-17 pathway and improving gut health.

## Contribution

This study identifies specific metabolites and their interactions with proteins in the IL-17 pathway to explain how oats and oat bran alleviate colitis.

## Key findings

- Three key metabolites were identified: ursodeoxycholic acid, 3-(3-hydroxyphenyl)propionic acid, and avenanthramide C.
- Oats and oat bran modulated the IL-17, PI3K-Akt, and TNF signaling pathways and upregulated tight junction proteins.
- Molecular docking showed stable binding between the metabolites and IL-17 pathway proteins, especially with ursodeoxycholic acid.

## Abstract

Background/Objectives: Diet plays a critical role in the development of inflammatory bowel disease (IBD). Our previous work demonstrated that oats and oat bran alleviate dextran sulfate sodium (DSS)-induced colitis in mice by modulating the gut microbiota. Methods: To further explore the underlying mechanisms, this study combined metabolomic and transcriptomic analyses to systematically compare the effects of whole oats and oat bran interventions on chronic colitis. Results: Untargeted metabolomics analysis identified three key metabolites, ursodeoxycholic acid, 3-(3-hydroxyphenyl)propionic acid, and avenanthramide C. The interactions between these metabolites and core proteins of the IL-17 signaling pathway (IL-17A, TRAF6, and ACT1) were evaluated via molecular docking. Transcriptomic and RT-qPCR analyses revealed that both oats and oat bran interventions modulated the IL-17, PI3K-Akt, and TNF signaling pathways. These treatments significantly upregulated the expression of tight junction proteins (claudin-1, claudin-5, occludin) while reducing levels of inflammatory cytokines and chemokines. Molecular docking results demonstrated stable binding between the three metabolites and target proteins primarily through hydrogen bonding and electrostatic interactions, with ursodeoxycholic acid exhibiting the highest binding affinity. Conclusions: Collectively, these findings suggest that oats and oat bran may alleviate chronic colitis by modulating the IL-17 signaling pathway and enhancing intestinal barrier function.

## Linked entities

- **Proteins:** IL17A (interleukin 17A), TRAF6 (TNF receptor associated factor 6), TRAF3IP2 (TRAF3 interacting protein 2), CLDN7 (claudin 7), cldn5.L (claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) L homeolog), si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3)
- **Chemicals:** ursodeoxycholic acid (PubChem CID 31401), 3-(3-hydroxyphenyl)propionic acid (PubChem CID 91), avenanthramide C (PubChem CID 11723200)
- **Diseases:** inflammatory bowel disease (MONDO:0005265)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), Chronic Colitis (MESH:D003092), IBD (MESH:D015212)
- **Chemicals:** avenanthramide C. (MESH:C514463), 3-(3-hydroxyphenyl)propionic acid (MESH:C038547), DSS (MESH:D016264), ursodeoxycholic acid (MESH:D014580)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12899893/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12899893/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12899893/full.md

---
Source: https://tomesphere.com/paper/PMC12899893